Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
No Opening Trades ; Clearing Issues
Only closing orders are permitted in this stock.
This is the highlight this am around Zenith,,,,,on my IB platform. Not sure just what it all implies!